LA JOLLA, Calif., March 20, 2025 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) today announced that it has entered into a definitive agreement to acquire Advanced AgProtection (“AAP”). Advanced AgProtection is a Texas-headquartered specialized Crop Managing General Agent. The AAP team is comprised of industry veterans with longstanding relationships and a proven track record in the Crop insurance sector. Palomar made a strategic investment in AAP in 2023 at the launch of the partnership between the two companies. The deal is expected to close during the second quarter of this year. Jon Christianson, President of Palomar, stated, “Building on our successful collaboration with Advanced AgProtection over the last two years, this acquisition marks a natural progression for Palomar and our Crop...

Sticker Mule’s X BotsMonthly engagement for Sticker Mule’s X Bots is skyrocketing.AMSTERDAM, N.Y., March 20, 2025 (GLOBE NEWSWIRE) — Sticker Mule, the Internet’s hottest printing company, has launched a suite of automated X bots. The bots help users print, frame, and edit images by replying to X posts. Sticker Mule entered the X bot space in June 2024 with its $100,000 acquisition of Pikaso, the most popular bot on X, which boasts nearly 1 million followers and 100 million monthly impressions. Pikaso turns X posts into shareable screenshots and continues to enjoy rapid growth. The bot continues to gain more than 25,000 followers per month with a 32% month-over-month increase in impressions. Pikaso was shut down completely at the time of the acquisition. X had implemented new API fees, and the indie company...

The acquisition enhances Cylinder’s diagnostic accuracy, expands clinical partnerships, and drives growth-focused trials CHICAGO, March 20, 2025 (GLOBE NEWSWIRE) — Cylinder, the leading virtual digestive health provider, today announced its acquisition of Dieta Health, creator of the first clinically validated AI-powered stool imaging app. This acquisition will drive Cylinder towards its goal of delivering more personalized digestive care and improving clinical outcomes. Dieta Health developed the world’s first mobile app with clinically-validated AI stool image classification. Traditionally, patients with GI conditions are often asked to observe their stool and report subjective outcomes — like the Bristol Stool Scale — which influences diagnosis and treatment decisions. Dieta’s app allows them to capture stool photos via smartphone,...

TELigence Partners, Brevin Systems and Calkins Networks expands the organization’s customer reach across the Northeastern U.S. PORTSMOUTH, N.H., March 20, 2025 (GLOBE NEWSWIRE) — Blue Mantis, a leading provider of digital strategy and services specializing in managed services, cybersecurity and cloud solutions, today announced the acquisition of three firms focused on IT, networking, telecommunications and managed services – TELigence Partners, Brevin Systems and Calkins Networks, each headquartered in Vermont with customers and employees located throughout the Northeast and greater U.S. The acquisition will bring nearly 200 new customers to Blue Mantis. Strategic Acquisitions Enhances Blue Mantis’ Network Services There is a growing need for carrier services and network security investments in the mid-market sector, as companies...

RADNOR, Pa., March 20, 2025 (GLOBE NEWSWIRE) — KnowFully Learning Group (“KnowFully”), a leading provider of continuing professional education, exam preparation, and digital learning solutions for the accounting, finance, and healthcare sectors, today announced the acquisition of EfficientCME, an innovative provider of continuing education for healthcare professionals. This acquisition strengthens the KnowFully Medical Education (KME) Division, which includes CME Outfitters (CMEO) and Creative Educational Concepts (CEC). With EfficientCME joining the KME family, KnowFully now brings together three of the most respected and trusted brands in continuing medical education (CME), reinforcing its commitment to delivering best-in-class education that improves clinical practice and patient outcomes. Expanding KME’s Reach &...

Strategic Acquisition Brings Mortgage and Liability Optimization Capabilities to Flourish’s Leading WealthTech Platform, Helping Independent Advisors Better Compete with Wirehouses and Banks Through Holistic Service Offering New York, March 20, 2025 (GLOBE NEWSWIRE) — Flourish, a platform that helps registered investment advisors (RIAs) grow by evolving from holistic advice to holistic implementation, today announced that it has entered into a definitive agreement to acquire Sora Finance (Sora), an AI-driven liability optimization platform for advisors. The acquisition creates one of the industry’s first comprehensive platforms addressing both asset and liability management for RIAs, empowering independent advisors to bring cash and lending services to their clients. Sora works with over 750 financial advisors, helping...

Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform The combined company would continue marketing Eyenovia’s FDA-approved products – and plans to in-license additional products to generate near-term revenue NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform, today announced that it has entered into a non-binding letter of intent (LOI) contemplating a potential reverse merger transaction with Betaliq, Inc., a clinical stage pharmaceutical company with a therapeutic focus...

Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and integrate seamlessly with Renovaro Biosciences PITTSBURGH, March 20, 2025 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has completed the sale of assets related to its wholly owned subsidiary, Skyline Medical Inc., to DeRoyal Industries, Inc., a global manufacturer and supplier of medical products. As previously disclosed, Skyline Medical’s business operated outside the core focus of Predictive Oncology, which is the use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of...

REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) —  Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma AB’s (“Xbrane”) R&D operations and a biosimilar candidate (the “Acquisition”), further expanding Alvotech’s development capabilities, and establishing a footprint in the Swedish life science sector. The Acquisition includes Xbrane’s R&D operations based in Campus Solna, at the Karolinska Institute outside Stockholm, Sweden, as well as the biosimilar candidate XB003, referencing Cimzia® (certolizumab pegol). Xbrane retains other pre-clinical assets and will focus on the commercialization of this portfolio. Alvotech also announced that it intends to explore...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma AB’s (“Xbrane”) R&D operations and a biosimilar candidate (the “Acquisition”), further expanding Alvotech’s development capabilities, and establishing a footprint in the Swedish life science sector. The Acquisition includes Xbrane’s R&D operations based in Campus Solna, at the Karolinska Institute outside Stockholm, Sweden, as well as the biosimilar candidate XB003, referencing Cimzia® (certolizumab pegol). Xbrane retains other pre-clinical assets and will focus on the commercialization of this portfolio. Alvotech also announced that it intends to explore the possibility of a listing of Swedish Depository Receipts (SDR), equity share...